NCT07827560 Acupressure to Improve Insomnia Among the Elderly With Hypertension
| NCT ID | NCT07827560 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Phenikaa University |
| Condition | Insomnia (Self-reported, Non-diagnosed) |
| Study Type | INTERVENTIONAL |
| Enrollment | 94 participants |
| Start Date | 2026-08-30 |
| Primary Completion | 2027-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 94 participants in total. It began in 2026-08-30 with a primary completion date of 2027-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate the feasibility and the effect of self-acupressure on improving insomnia among the elderly with hypertension who reported insomnia (using the Insomnia Severity Index questionnaire) The main questions it aims to answer are: * Is the proposed intervention feasible to deliver to the target population in terms of recruitment, retention, adherence, and completion of outcome assessments? * Does self-acupressure improve insomnia among the elderly with hypertension? Researchers will compare participants in the self-acupressure group (practice acupressure at home for 28 days) and the enhanced standard care group to see the effectiveness of acupressure in improving insomnia for hypertensive elderly individuals. Participants in the self-acupressure group will be instructed how to locate and perform acupressure, then they will be asked to practice acupressure at home for 28 days (once a day). Participants in the enhanced standard care group will receive training on how to apply sleep hygiene rules and will be asked to follow sleep hygiene rules for 28 days.
Eligibility Criteria
Inclusion Criteria: * Hypertention patient who are ≥ 60 years old * Having Insomnia Severity Index score ≥ 11 * Having Karnofsky score ≥ 80. Exclusion Criteria: * Patients who are currently participating in clinical trials for the treatment of insomnia. * Patients who are currently receiving pharmacological treatment for insomnia. * Patients with concomitant cardiovascular conditions, such as heart failure; patients with an implanted pacemaker; patients who have an indication for catheter-based cardiovascular intervention; or patients who have an indication for cardiovascular surgery. * Patients with psychiatric disorders, such as depression, generalized anxiety disorder, or bipolar disorder.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07827560 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Insomnia (Self-reported, Non-diagnosed). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07827560 currently recruiting?
Yes, NCT07827560 is actively recruiting participants. Contact the research team at huong.hoangthixuan@phenikaa-uni.edu.vn for enrollment information.
Where is the NCT07827560 trial being conducted?
This trial is being conducted at Hanoi, Vietnam.
Who is sponsoring the NCT07827560 clinical trial?
NCT07827560 is sponsored by Phenikaa University. The trial plans to enroll 94 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.